Study guide

Retinitis pigmentosa and inherited degeneration

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Retinitis pigmentosa and inherited degeneration

Key Takeaways Explain This Topic AI

Rod-first disease commonly produces night and peripheral-vision difficulty before major central loss.

Inheritance and molecular findings vary, so a pigmentary phenotype is not a complete genetic diagnosis.

Assess complications, systemic associations and rehabilitation while arranging appropriate genetic counselling.

Last updated: October 2026

Retinitis Pigmentosa (RP)

Retinitis pigmentosa (RP) encompasses a clinically and genetically heterogeneous group of inherited rod-cone dystrophies characterized by primary progressive degeneration of rod photoreceptors, followed inevitably by secondary apoptotic death of cone photoreceptors. It represents the single most common inherited retinal dystrophy, with an estimated prevalence of 1 in 3,500 to 1 in 4,000 individuals (~1.5 million people worldwide).

Inheritance Modes & Molecular Genetics

RP demonstrates extensive genetic heterogeneity, with over 80 causative genes identified across all modes of Mendelian inheritance:

Autosomal Dominant RP (AD-RP): Typically displays the mildest clinical course, slowest progression, and best visual prognosis, with central vision often preserved beyond the sixth decade. The most common genetic causes are mutations in RHO (rhodopsin, accounting for 25–30% of AD-RP), PRPF31 (pre-mRNA processing factor 31; exhibits non-penetrance), and RP1 .

Autosomal Recessive RP (AR-RP): Displays intermediate clinical severity. Mutations in USH2A represent the most common cause of both non-syndromic AR-RP and Usher syndrome type 2. Other common genes include PDE6A , PDE6B (phosphodiesterase 6 subunits), and CNGA1 .

X-Linked RP (XL-RP): Represents the most aggressive and devastating form. Hemizygous males manifest severe night blindness in early childhood and rapid peripheral field constriction, frequently progressing to legal blindness by their third or fourth decade. Mutations in RPGR (retinitis pigmentosa GTPase regulator) account for > 70 % >70\% > 70% of all XL-RP , with RP2 accounting for 10–20%. Heterozygous carrier females often exhibit a characteristic, reflective, golden-metallic tapetal-like retinal sheen in the posterior pole.

Simplex RP describes an isolated family presentation, not a separate mode of inheritance. Recessive disease, new dominant variants, X-linked disease and incomplete family information can all produce this pattern. Confirm genotype and pedigree before recurrence-risk counselling.

Pathophysiological Cascade: From Rod to Cone Death

The pathogenic mutations primarily affect rod-specific phototransduction proteins, cilia structural components, or retinal pigment epithelium (RPE) phagocytic mechanisms. Degeneration begins in the mid-periphery where rod density is physiologically highest: Primary Rod Degeneration ⟹ Loss of RdCVF + Hyperoxia & ROS ⟹ Secondary Cone Apoptosis ⟹ Central Blindness \text{Primary Rod Degeneration} \implies \text{Loss of RdCVF} + \text{Hyperoxia \& ROS} \implies \text{Secondary Cone Apoptosis} \implies \text{Central Blindness} Primary Rod Degeneration ⟹ Loss of RdCVF + Hyperoxia & ROS ⟹ Secondary Cone Apoptosis ⟹ Central Blindness

Secondary cone loss is mediated by two non-cell-autonomous mechanisms:

Loss of Rod-Derived Cone Viability Factor (RdCVF): Healthy rods continuously secrete RdCVF (encoded by the NXNL1 gene), a thioredoxin-like trophic factor that binds to basigin-1 on cone photoreceptors, accelerating glucose uptake and aerobic glycolysis. When rods degenerate, the deprivation of RdCVF causes cone starvation and metabolic collapse.

Hyperoxia and Oxidative Stress: As rods die, consumption of oxygen delivered by the unyielding choriocapillaris plummets. The resulting hyperoxic microenvironment generates toxic reactive oxygen species (ROS), driving oxidative apoptosis of residual cones.

Classical Clinical Triad & Chronological Symptoms

Presenting Symptom: Nyctalopia (night blindness) is the universal earliest manifestation, typically recognized during childhood or early adolescence.

Visual Field Progression: Loss of mid-peripheral rods produces an initial patchy ring scotoma that coalesces into a dense mid-peripheral annular scotoma. The scotoma gradually expands centripetally and centrifugally, leaving a constricted central tunnel of vision ( "tunnel vision" ).

The Classical Diagnostic Triad on Funduscopy:

Bone-Spicule Intraretinal Pigmentation: Dark, stellate, branching hyperpigmented deposits situated in the mid-periphery, predominantly along the adventitia of retinal vessels. As rods degenerate, RPE cells detach from Bruch's membrane, migrate into the inner sensory retina, and cluster around retinal venules, releasing melanin granules.

Marked Arteriolar Attenuation: Severe narrowing and "thread-like" thinning of retinal arterioles, resulting from reduced metabolic demand of the atrophied retina and local endothelin-mediated vasoconstriction.

Waxy Optic Disc Pallor: The optic nerve head exhibits a yellowish-waxy, pale appearance caused by diffuse astrocytic glial proliferation (gliosis) covering the disc surface, rather than true primary descending axonal atrophy.

Associated Ocular Complications

Posterior Subcapsular Cataract (PSC): Develops in 40% to 50% of RP patients at a relatively young age (3rd–5th decades). Surgical phacoemulsification yields substantial subjective visual improvement, provided the fovea is functional.

Cystoid Macular Oedema (CMO): Occurs in 10% to 20% of RP eyes , driven by blood-retinal barrier breakdown and chronic low-grade inflammation. First-line therapy is oral carbonic anhydrase inhibitors (acetazolamide 250 − 500 mg/day 250-500\,\text{mg/day} 250 − 500 mg/day ) or topical dorzolamide 2% TDS. Notably, RP-associated CMO responds poorly to anti-VEGF therapy.

Other Associations: Keratoconus, high myopia, optic disc drusen, and vitreous condensation (pigmented vitreous cells and posterior vitreous detachment).

Systemic Syndromes Associated with Retinitis Pigmentosa

Syndrome Inheritance & Gene Distinctive Systemic Manifestations Key Clinical Pearls for the EBOD

Usher Syndrome AR ( MYO7A , USH2A , CLRN1 ) RP + Sensorineural Hearing Loss Type 1: Profound congenital deafness, absent vestibular function (delayed motor milestones), early RP; Type 2: Moderate congenital hearing loss, normal vestibular function, adolescent RP; Type 3: Progressive hearing loss and variable vestibular dysfunction.

Bardet-Biedl Syndrome AR (Ciliopathy, BBS1-BBS21 ) RP + Polydactyly + Obesity + Renal Dysplasia Postaxial polydactyly (hands/feet), central truncal obesity, learning difficulties, hypogonadism, and progressive renal impairment (leading cause of mortality).

Refsum Disease AR ( PHYH / Phytanoyl-CoA hydroxylase) RP + Cerebellar Ataxia + Polyneuropathy Accumulation of phytanic acid . Presents with anosmia, ichthyosis, epiphyseal dysplasia, and cardiac arrhythmias. Treatable by strict dietary restriction of phytanic acid (dairy and ruminant fats).

Abetalipoproteinaemia (Bassen-Kornzweig) AR ( MTTP mutation) RP + Ataxia + Fat Malabsorption Failure of microsomal triglyceride transfer and assembly of apoB-containing lipoproteins; absence of chylomicrons/VLDL/LDL. Peripheral blood smear reveals acanthocytosis (spiculated RBCs). Requires specialist nutritional treatment with fat-soluble vitamins and metabolic monitoring.

Kearns-Sayre Syndrome Mitochondrial DNA deletion Pigmentary Retinopathy + CPEO + Heart Block Manifests before age 20 with atypical "salt-and-pepper" retinopathy, chronic progressive external ophthalmoplegia (CPEO), and complete cardiac heart block requiring cardiac assessment and pacing according to conduction disease and specialist risk assessment. Ragged-red fibres on muscle biopsy.

Sections you finish are checked off in the contents.

  • Up Next
  • Stargardt, Best disease and retinal electrophysiology
  • Continue learning